These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12614184)

  • 1. The cost of adverse drug reactions.
    Gautier S; Bachelet H; Bordet R; Caron J
    Expert Opin Pharmacother; 2003 Mar; 4(3):319-26. PubMed ID: 12614184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods and systems to detect adverse drug reactions in hospitals.
    Thürmann PA
    Drug Saf; 2001; 24(13):961-8. PubMed ID: 11735652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics of adverse drug reactions.
    Lundkvist J; Jönsson B
    Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
    Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
    BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systematic review of studies assessing the cost of adverse drug reactions].
    Vallano Ferraz A; Agustí Escasany A; Pedrós Xolvi C; Arnau de Bolós JM
    Gac Sanit; 2012; 26(3):277-83. PubMed ID: 22152925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and evaluation of adverse drug effects].
    Thürmann PA; Schmitt K
    Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic impact of adverse drug reactions in hospitalized patients.
    Suh DC; Woodall BS; Shin SK; Hermes-De Santis ER
    Ann Pharmacother; 2000 Dec; 34(12):1373-9. PubMed ID: 11144691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database.
    Maity T; Longo C
    BMC Health Serv Res; 2021 Nov; 21(1):1231. PubMed ID: 34774053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the direct cost of adverse drug reactions in hospitalised patients.
    Bordet R; Gautier S; Le Louet H; Dupuis B; Caron J
    Eur J Clin Pharmacol; 2001 Mar; 56(12):935-41. PubMed ID: 11317484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with preventable adverse drug reactions.
    Pearson TF; Pittman DG; Longley JM; Grapes ZT; Vigliotti DJ; Mullis SR
    Am J Hosp Pharm; 1994 Sep; 51(18):2268-72. PubMed ID: 7801987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of outpatient adverse drug reactions leading to hospitalization.
    Wu WK; Pantaleo N
    Am J Health Syst Pharm; 2003 Feb; 60(3):253-9. PubMed ID: 12613234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission.
    Goettler M; Schneeweiss S; Hasford J
    Pharmacoepidemiol Drug Saf; 1997 Oct; 6 Suppl 3():S79-90. PubMed ID: 15073758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
    Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
    Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of preventable adverse drug reactions: a systematic review of observational studies.
    Formica D; Sultana J; Cutroneo PM; Lucchesi S; Angelica R; Crisafulli S; Ingrasciotta Y; Salvo F; Spina E; Trifirò G
    Expert Opin Drug Saf; 2018 Jul; 17(7):681-695. PubMed ID: 29952667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.